NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease

Abstract The neuromuscular junction (NMJ) is the peripheral synapse formed between a motor neuron axon terminal and a muscle fibre. NMJs are thought to be the primary site of peripheral pathology in many neuromuscular diseases, but innervation/denervation status is often assessed qualitatively with...

Full description

Bibliographic Details
Main Authors: Alan Mejia Maza, Seth Jarvis, Weaverly Colleen Lee, Thomas J. Cunningham, Giampietro Schiavo, Maria Secrier, Pietro Fratta, James N. Sleigh, Elizabeth M. C. Fisher, Carole H. Sudre
Format: Article
Language:English
Published: Nature Portfolio 2021-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-91094-6
_version_ 1818435105525334016
author Alan Mejia Maza
Seth Jarvis
Weaverly Colleen Lee
Thomas J. Cunningham
Giampietro Schiavo
Maria Secrier
Pietro Fratta
James N. Sleigh
Elizabeth M. C. Fisher
Carole H. Sudre
author_facet Alan Mejia Maza
Seth Jarvis
Weaverly Colleen Lee
Thomas J. Cunningham
Giampietro Schiavo
Maria Secrier
Pietro Fratta
James N. Sleigh
Elizabeth M. C. Fisher
Carole H. Sudre
author_sort Alan Mejia Maza
collection DOAJ
description Abstract The neuromuscular junction (NMJ) is the peripheral synapse formed between a motor neuron axon terminal and a muscle fibre. NMJs are thought to be the primary site of peripheral pathology in many neuromuscular diseases, but innervation/denervation status is often assessed qualitatively with poor systematic criteria across studies, and separately from 3D morphological structure. Here, we describe the development of ‘NMJ-Analyser’, to comprehensively screen the morphology of NMJs and their corresponding innervation status automatically. NMJ-Analyser generates 29 biologically relevant features to quantitatively define healthy and aberrant neuromuscular synapses and applies machine learning to diagnose NMJ degeneration. We validated this framework in longitudinal analyses of wildtype mice, as well as in four different neuromuscular disease models: three for amyotrophic lateral sclerosis (ALS) and one for peripheral neuropathy. We showed that structural changes at the NMJ initially occur in the nerve terminal of mutant TDP43 and FUS ALS models. Using a machine learning algorithm, healthy and aberrant neuromuscular synapses are identified with 95% accuracy, with 88% sensitivity and 97% specificity. Our results validate NMJ-Analyser as a robust platform for systematic and structural screening of NMJs, and pave the way for transferrable, and cross-comparison and high-throughput studies in neuromuscular diseases.
first_indexed 2024-12-14T16:47:36Z
format Article
id doaj.art-3ff0e26ea9ca4cddb08257a5dd74ce5e
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T16:47:36Z
publishDate 2021-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-3ff0e26ea9ca4cddb08257a5dd74ce5e2022-12-21T22:54:08ZengNature PortfolioScientific Reports2045-23222021-06-0111111710.1038/s41598-021-91094-6NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular diseaseAlan Mejia Maza0Seth Jarvis1Weaverly Colleen Lee2Thomas J. Cunningham3Giampietro Schiavo4Maria Secrier5Pietro Fratta6James N. Sleigh7Elizabeth M. C. Fisher8Carole H. Sudre9Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonMammalian Genetics Unit, MRC Harwell InstituteDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonDepartment of Genetics, Evolution and Environment, UCL Genetic Institute, University College LondonDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College LondonMRC Unit for Lifelong Health and Ageing, Department of Population Science and Experimental Medicine, University College LondonAbstract The neuromuscular junction (NMJ) is the peripheral synapse formed between a motor neuron axon terminal and a muscle fibre. NMJs are thought to be the primary site of peripheral pathology in many neuromuscular diseases, but innervation/denervation status is often assessed qualitatively with poor systematic criteria across studies, and separately from 3D morphological structure. Here, we describe the development of ‘NMJ-Analyser’, to comprehensively screen the morphology of NMJs and their corresponding innervation status automatically. NMJ-Analyser generates 29 biologically relevant features to quantitatively define healthy and aberrant neuromuscular synapses and applies machine learning to diagnose NMJ degeneration. We validated this framework in longitudinal analyses of wildtype mice, as well as in four different neuromuscular disease models: three for amyotrophic lateral sclerosis (ALS) and one for peripheral neuropathy. We showed that structural changes at the NMJ initially occur in the nerve terminal of mutant TDP43 and FUS ALS models. Using a machine learning algorithm, healthy and aberrant neuromuscular synapses are identified with 95% accuracy, with 88% sensitivity and 97% specificity. Our results validate NMJ-Analyser as a robust platform for systematic and structural screening of NMJs, and pave the way for transferrable, and cross-comparison and high-throughput studies in neuromuscular diseases.https://doi.org/10.1038/s41598-021-91094-6
spellingShingle Alan Mejia Maza
Seth Jarvis
Weaverly Colleen Lee
Thomas J. Cunningham
Giampietro Schiavo
Maria Secrier
Pietro Fratta
James N. Sleigh
Elizabeth M. C. Fisher
Carole H. Sudre
NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
Scientific Reports
title NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
title_full NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
title_fullStr NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
title_full_unstemmed NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
title_short NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
title_sort nmj analyser identifies subtle early changes in mouse models of neuromuscular disease
url https://doi.org/10.1038/s41598-021-91094-6
work_keys_str_mv AT alanmejiamaza nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT sethjarvis nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT weaverlycolleenlee nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT thomasjcunningham nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT giampietroschiavo nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT mariasecrier nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT pietrofratta nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT jamesnsleigh nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT elizabethmcfisher nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease
AT carolehsudre nmjanalyseridentifiessubtleearlychangesinmousemodelsofneuromusculardisease